PS
ALT icon

Principal Securities’s Altimmune ALT Stock Holding History

Principal Securities’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35
Closed -$135 – 3733
2025
Q2 		$135 Buy
+35
New +$189 ﹤0.01% 3629
2024
Q2 		– Sell
-18
Closed -$183 – 3393
2024
Q1 		$183 Buy
+18
New +$183 ﹤0.01% 3249

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Principal Securities's ALT Position: Q3 2025 in Review

Principal Securities sold out of Altimmune (ALT) in Q3 2025, closing a stake of 35 shares — an estimated $135 sold.

Principal Securities first reported a position in ALT in Q1 2024 and held it in 2 quarters. The position peaked at $183 in Q1 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Principal Securities reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Principal Securities sold 35 Altimmune shares in Q3 2025, an estimated $135.
  • Principal Securities first reported a position in Altimmune in Q1 2024 and held it in 2 quarters.
  • Principal Securities's Altimmune position peaked at $183 in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Principal Securities's 13F filing for Q3 2025, filed 12 Nov 2025.